RX PLUS LTD

Company number 15981854 · Active

RX PLUS LTD is a private limited company registered in LEEDS, United Kingdom, incorporated on 26 Sep 2024. Its registered activity is dispensing chemist in specialised stores. Its latest published accounts for the period ending 30 Sep 2025 show equity of −£275, total assets of £225. It has filed 1 set of accounts, 1 of them after the deadline.

Company details

Company number
15981854 · official register
Status
Active
Legal form
Private Limited Company
Incorporated
26 Sep 2024 (2 years)
Registered address
LS11 7NN LEEDS
Postcode area
Leeds
Activity
47730 Dispensing chemist in specialised stores
Industry
Retail trade
Accounts overdue
No

Insolvency and register events

No insolvency or liquidation events on record.

Annual accounts GBP

Period endPublishedTurnoverResultEquityTotal assetsCurrent liabilitiesCashEmployees
30 Sep 20251 Oct 2026– –−£275£225 £0£2243

As published. Small companies often file a balance sheet only, so turnover and result can be missing.

Similar companies in Leeds

Questions about RX PLUS LTD

What is the company number of RX PLUS LTD?

RX PLUS LTD is registered under company number 15981854 in the official register of United Kingdom. View it at the official register.

Is RX PLUS LTD still active?

Yes. RX PLUS LTD is registered as active (status: Active).

Has RX PLUS LTD gone bankrupt or into insolvency?

No insolvency, bankruptcy or administration is recorded for RX PLUS LTD in the official data.

When was RX PLUS LTD founded?

RX PLUS LTD was incorporated on 26 Sep 2024.

Where is RX PLUS LTD registered?

RX PLUS LTD's registered address is in LS11 7NN LEEDS (Leeds), United Kingdom.

What do the latest accounts of RX PLUS LTD show?

The latest published accounts (period ending 30 Sep 2025) show equity of −£275, total assets of £225, 3 employees.

Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 7 Nov 2026.